Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Percutaneous Biopsy After Neoadjuvant Chemotherapy.

NCT: NCT07644455 · NOT_YET_RECRUITING

NCT IDNCT07644455
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2026-12
SponsorInstituto do Cancer do Estado de São Paulo (OTHER)
First posted
Last updated

Brief Summary

Neoadjuvant chemotherapy is widely used in the treatment of locally advanced breast cancer or in early stages of triple-negative or HER2 overexpressing tumors. Pathological complete response (pCR) to neoadjuvant chemotherapy is associated with better clinical outcomes. However, confirmation of pCR still depends on surgery, which may represent overtreatment for some patients. In this context, image-guided vacuum-assisted percutaneous biopsy (VAB) has been investigated as an alternative to assess tumor response and potentially avoid breast surgery in the future. However, there are no studies evaluating this strategy in brazilian patients, the majority of whom present with locally advanced tumors at diagnosis.

Frequently Asked Questions

What is Percutaneous Biopsy After Neoadjuvant Chemotherapy.?

Percutaneous Biopsy After Neoadjuvant Chemotherapy. is a clinical trial registered under NCT07644455. Current status: NOT_YET_RECRUITING.

What is the status of NCT07644455?

The current status of NCT07644455 (Percutaneous Biopsy After Neoadjuvant Chemotherapy.) is: NOT_YET_RECRUITING.

When did Percutaneous Biopsy After Neoadjuvant Chemotherapy. start?

Percutaneous Biopsy After Neoadjuvant Chemotherapy. started on 2026-06.

Related Devices

K202012Mammotome Revolve Dual Vacuum Assisted Biopsy (VAB) SystemDevicor Medical Products, Inc. K260365Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Battery CharDevicor Medical Products, Inc. K180233Eviva Stereotactic Guided Breast Biopsy SystemHologic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑